Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET) imaging agent flortaucipir F-18 met its two primary endpoints, defined as predicting brain tau pathology and predicting Alzheimer's disease diagnosis.

Novarad Healthcare Enterprise Imaging has taken the highest rated spot on Gartner’s Peer Insights technology review platform, outranking every other competitor in the vendor-neutral archive (VNA) market category.

Agfa HealthCare and Greenville Health System (GHS), South Carolina, announced the successful implementation of a comprehensive enterprise imaging system. The implementation will facilitate greater efficiencies in clinical operations, improve clinical confidence, and enable cost reduction through convergence of systems and timely access to medical images and diagnostic tools.

A new report from data and analytics company GlobalData suggests that Amazon is poised to make huge strides in healthcare as the Internet retail giant prepares to enter a new market. The report highlights a business model that facilitates easier connectivity between providers and patients, a powerful online platform and its artificial intelligence (AI) interface, Alexa.

August 30, 2018 — Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) ...

A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to new research in Journal of the American Heart Association.

August 28, 2018 — A new study has demonstrated a method that produces novel light beams from synchrotron light sources ...

In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon emission computed tomography (SPECT) scans to investigate factors that accelerate brain aging. The study — conducted by scientists from Amen Clinics (Costa Mesa, Calif.), Google, Johns Hopkins University, University of California Los Angeles and the University of California San Francisco — encompassed more than 30,000 individuals from 9 months old to 105 years of age.

Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil beam scanning (PBS) treatments at its Proton Beam Cancer Center. On May 15, the center carried out the world’s first patient treatment using RayStation together with Mitsubishi Electric’s proton therapy system, with a plan created in RayStation 6.

Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of events occurring after radiation than to remember pre-treatment happenings, according to a Baylor University study. The study compared these children to children with healthy brains.